Skip to main content
NCBI home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1994 Jan;78(1):4–7. doi: 10.1136/bjo.78.1.4

Reduction of macular oedema by acetazolamide in patients with chronic iridocyclitis: a randomised prospective crossover study.

M D Farber 1, S Lam 1, H H Tessler 1, T J Jennings 1, A Cross 1, M M Rusin 1
PMCID: PMC504681  PMID: 8110697

Abstract

Thirty patients with cystoid macular oedema secondary to chronic iridocyclitis were enrolled in a two period, prospective, randomised, double masked, crossover study that compared sustained release acetazolamide (500 mg twice a day) with a placebo to measure the effects on the reduction of cystoid macular oedema and improvement of visual acuity. All patients were treated for 1 month with either acetazolamide or placebo, received no treatment for 1 month, and were then treated for 1 month with the other medication. Statistically significant improvement in visual acuity was seen at 14 and 28 days in the treated patients. No improvement was seen when patients received placebo. Improved visual acuity was not associated with race or sex. However, younger patients (under age 55 years) were more likely to benefit from treatment. Results of vitreous fluorophotometry, obtained at baseline and 4 weeks, demonstrated an improvement in posterior vitreous penetration ratios and mid vitreous penetration ratios after treatment with acetazolamide but not with placebo.

Full text

PDF
4

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blair N. P., Elman M. J., Rusin M. M. Vitreous fluorophotometry in patients with cataract surgery. Graefes Arch Clin Exp Ophthalmol. 1987;225(6):441–446. doi: 10.1007/BF02334173. [DOI] [PubMed] [Google Scholar]
  2. Cox S. N., Hay E., Bird A. C. Treatment of chronic macular edema with acetazolamide. Arch Ophthalmol. 1988 Sep;106(9):1190–1195. doi: 10.1001/archopht.1988.01060140350030. [DOI] [PubMed] [Google Scholar]
  3. Cunha-Vaz J. G., Gray J. R., Zeimer R. C., Mota M. C., Ishimoto B. M., Leite E. Characterization of the early stages of diabetic retinopathy by vitreous fluorophotometry. Diabetes. 1985 Jan;34(1):53–59. doi: 10.2337/diab.34.1.53. [DOI] [PubMed] [Google Scholar]
  4. Cunha-Vaz J. G., Mota C. C., Leite E. C., Abreu J. R., Ruas M. A. Effect of sulindac on the permeability of the blood-retinal barrier in early diabetic retinopathy. Arch Ophthalmol. 1985 Sep;103(9):1307–1311. doi: 10.1001/archopht.1985.01050090059032. [DOI] [PubMed] [Google Scholar]
  5. Ferris F. L., 3rd, Kassoff A., Bresnick G. H., Bailey I. New visual acuity charts for clinical research. Am J Ophthalmol. 1982 Jul;94(1):91–96. [PubMed] [Google Scholar]
  6. Jennings T., Rusin M. M., Tessler H. H., Cunha-Vaz J. G. Posterior sub-Tenon's injections of corticosteroids in uveitis patients with cystoid macular edema. Jpn J Ophthalmol. 1988;32(4):385–391. [PubMed] [Google Scholar]
  7. Marmor M. F., Negi A. Pharmacologic modification of subretinal fluid absorption in the rabbit eye. Arch Ophthalmol. 1986 Nov;104(11):1674–1677. doi: 10.1001/archopht.1986.01050230112043. [DOI] [PubMed] [Google Scholar]
  8. Nussenblatt R. B., Kaufman S. C., Palestine A. G., Davis M. D., Ferris F. L., 3rd Macular thickening and visual acuity. Measurement in patients with cystoid macular edema. Ophthalmology. 1987 Sep;94(9):1134–1139. doi: 10.1016/s0161-6420(87)33314-7. [DOI] [PubMed] [Google Scholar]
  9. Rusin M. M., Fishman G. A., Larson J. A., Gilbert L. D. Vitreous fluorophotometry in carriers of choroideremia and X-linked retinitis pigmentosa. Arch Ophthalmol. 1989 Feb;107(2):209–212. doi: 10.1001/archopht.1989.01070010215025. [DOI] [PubMed] [Google Scholar]
  10. Tsuboi S., Pederson J. E. Experimental retinal detachment. X. Effect of acetazolamide on vitreous fluorescein disappearance. Arch Ophthalmol. 1985 Oct;103(10):1557–1558. doi: 10.1001/archopht.1985.01050100133034. [DOI] [PubMed] [Google Scholar]
  11. Zeimer R. C., Blair N. P., Cunha-Vaz J. G. Vitreous fluorophotometry for clinical research. I. Description and evaluation of a new fluorophotometer. Arch Ophthalmol. 1983 Nov;101(11):1753–1756. doi: 10.1001/archopht.1983.01040020755019. [DOI] [PubMed] [Google Scholar]
  12. Zeimer R. C., Blair N. P., Cunha-Vaz J. G. Vitreous fluorophotometry for clinical research. II. Method of data acquisition and processing. Arch Ophthalmol. 1983 Nov;101(11):1757–1761. doi: 10.1001/archopht.1983.01040020759020. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES